The South African Pharmacy Council, Health Professions Council of South Africa and the South African Health Products Regulatory Authority hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS Semaglutide, iDEXIS Tirzepatide, and iDEXIS Semaglutide/Tirzepatide recalled by SAHPRA in June 2026
However, the inventors also suggested that the peptide could be used not only to treat MS itself, either alone or with concomitant corticosteroid therapy, but also to prevent relapse or to treat MS in remission
While powerful on their own, NAD+ vs Glutathione IV Therapy is more effective when combined
Seuns Calendly app here.
The woman, who lives in Louisiana, lost around 150 pounds on the two medications, according to her attorney, Paul Pennock, a New York City-based attorney for Morgan & Morgan, According to the lawsuit, the woman, who has not been officially diagnosed with gastroparesis, suffered "severe gastrointestinal events," including, "severe vomiting, stomach pain, [and] gastrointestinal burning." "Her problems have been so severe that she's been to the emergency room multiple times, including last week," Pennock told ABC News Wednesday
Strong safety record across clinical reviews
